Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.The acquisition to expand therapeutic capabilities of Medpace in Europe
Subscribe to our email newsletter
Medpace has entered into a purchase agreement to acquire Pharma Brains , an oncology focused CRO based in Basel, Switzerland. Pharma Brains is expected to provide Medpace with complementary therapeutic expertise, leadership and qualified staff. Pharma Brains is led by president and CEO, Marc Salzberg, a research professional with experience in oncology phase I-IV studies as well as drug development and regulatory affairs.
The integration of Pharma Brains operations is expected to begin immediately with the intent of completing the merger by the end of 2009.
August Troendle, president and CEO of Medpace, said: “I am pleased to have Dr. Salzberg joining the group as an integral leader beginning with the integration and going forward as the VP of Oncology, Europe and General Manager, Switzerland. Marc Salzberg is a distinguished professional in European drug development and brings 17 years of industry and leadership experience to Medpace.”
Medpace is a global full-service clinical research organisation providing phase I-IV core development services for drug, biologic, and device programs.